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A previously healthy 40-year-old man was referred from
another hospital where he was initially admitted for a 4-day
history of nausea, general weakness, abdominal pain,
diarrhea, and progressive oligo-anuria. The patient was
oriented and had no neurological deficit.
Initial laboratory data showed acute renal failure and
anion-gap metabolic acidosis (Table 1).
On further questioning, the patient admitted having
inadvertently ingested an uncolored, sweet-tasting beverage
that was offered to him 5 days earlier as a ‘special drink’ by a
colleague on a building site. Serum toxicological screening
failed to detect methanol, ethylene glycol, or ethanol. No
sample of the liquid was available for composition analysis.
Serum osmolality was measured and osmolal gap was normal
(Table 1).
Urinalysis revealed mild proteinuria (1.5 g/day). Urine
sediment was normal, without crystalluria. The kidney
biopsy revealed acute and extensive tubular injuries, without
intratubular oxalate crystals.
Intermittent hemodialysis was initiated. A transient
increase in liver and pancreatic enzymes was noted (alanine
aminotransferase 174 IU/l, aspartate aminotransferase
121 IU/l, lipase 914 IU/l).
By the seventh day, the patient became apathic and
obnubilated. He developed a flaccid tetraparesis, an acute loss
of visual acuity—1/10 (left) and 3/10 (right)—and a
peripheral facial diplegia (Figure 1). Brain magnetic
resonance imaging and peripheral electromyography were
normal. Facial electromyography confirmed a severe axonal
neuropathy. Cerebrospinal fluid (CSF) analysis revealed
isolated high protein concentration (183mg/dl). Fundo-
scopic examination showed bilateral papillary edema. Optic
neuropathy was assessed by pattern-reversal visual evoked
potentials.
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Table 1 | Initial laboratory data
Reference values Admission Day 3
Creatinine (mg/dl) o1.2 4.2 10.6
Blood urea nitrogen (mg/dl) o26 51 78
Bicarbonates (mmol/l) 22–30 18 22
Sodium (mmol/l) 135–145 138 136
Potassium (mmol/l) 3.5–5.0 3.6 3.9
Chloride (mmol/l) 95–107 103 95
Glucose (mg/dl) 70–110 105 70
Measured osmolality (mOsm/l) 285–295 NA 307
Calculated osmolality (mOsm/l) = 2Na++BUN (mg/dl)/2.8+glucose (mg/dl)/18
(N: 285–290mOsm/l).
Osmolal gap =measured serum osmolalitycalculated osmolality (No10mOsm/l).
Figure 1 | Lower motor neuron facial diplegia with
lagophthalmos (Bell’s sign) and inability to close the mouth
and lower lip.
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The Diagnosis | Diethylene glycol poisoning
Intoxications resulting in acute renal failure, metabolic
acidosis, and neurological abnormalities should prompt the
clinician to look for toxic alcohol ingestion (Table 2).1,2
In our patient, diethylene glycol (DEG) intoxication was
strongly suggested by the association of peripheral facial
diplegia, flaccid tetraparesis, mild hepatitis, and pancreatitis.
An increased osmolal gap can contribute to the diagnosis of
toxic alcohol poisoning, and can be noted in patients
presenting soon after the ingestion.3 However, as noted in
our patient, a normal osmolal gap does not exclude the
diagnosis, as metabolization of DEG in weak acids leads to a
decrease in the osmolal gap and the appraisal of metabolic
acidosis in patients who are seen more than 24 h after
ingestion.1 Measurement of DEG serum concentration
establishes the definitive diagnosis; unfortunately, it is not
routinely performed and presumptive diagnosis often relies
on history and clinical presentation.2
DEG is a colorless, odorless liquid with a sweetish taste
and is used as a component of antifreeze formulations, brake
fluids, and as an illegal adulterant in ethanol spirits or in
medications.2 DEG has been responsible for outbreaks of
mass poisoning associated with its use as a solvent for
medications. DEG is metabolized in the liver to form its toxic
metabolite 2-hydroxyethoxyacetic acid and not, as initially
expected, two molecules of ethylene glycol; as a result,
poisoned patients do not display oxalate crystal formation in
the urine. The plasmatic half-life of DEG is 4–6 h in rats; the
half-life in humans and in case of renal failure remains
unknown.1 Early manifestations of DEG poisoning include
gastrointestinal symptoms, altered mental status, and meta-
bolic acidosis. A second phase is marked by hepatic and
particularly renal tubular injury. Delayed neurotoxicity
includes cranial nerve abnormalities (facial weakness, bulbar
palsy, optic neuritis), and peripheral neuropathy with
increased CSF protein concentration.4 Facial nerve palsy
appears to be a predominant neurological finding, as 50% of
the contaminated patients in Panama’s outbreak of 2006 were
affected and 82% of them presented with facial diplegia.
Late referral did not allow alcohol-dehydrogenase block-
ade by fomepizole or ethanol in our patient, who was treated
by intermittent hemodialysis and supportive measures.5
The vision recovered early, whereas tetraparesis began to
resolve on day 27. Renal replacement therapy was interrupted
on day 28 and the patient was able to walk on day 34.
Eight months later, complete peripheral facial diplegia and a
slight impairment in renal function (creatinine 1.7mg/dl)
persisted.
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Table 2 | Differential diagnosis of toxic alcohols poisoning
Methanol poisoning PG poisoning EG poisoning DEG poisoning
Acute renal failure +/ + + +
Metabolic acidosis + + + +
Osmolal gap =/m =/m =/m =/m
Neurological signsa +  + +
Cranial nerve palsy   Rare Frequent
Visual disturbances +   +
Calcium oxalate crystalluriab   + 
Mild hepatitis    +
Abbreviations: DEG, diethylene glycol; EG, ethylene glycol; PG, propylene glycol.
aComa in the severe forms of methanol and EG poisoning; encephalopathy and peripheral neuropathy more frequent in DEG poisoning.
bInconstant in EG poisoning but could persist for as long as 40 h in the absence of renal failure and up to 4 days in its presence.
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